Analyst Vernon Bernardino from H.C. Wainwright, who reiterated a buy rating and $19 price target on ARDS, told investors Wednesday that Aridis Pharmaceuticals Inc 's monoclonal Covid-19 Antibody Cocktail is potentially First-in-Class treatment: "the cocktail binds to the S2 spike protein subunit, which mediates viral cell membrane fusion in SARS-CoV-2 variants...
HC Wainwright & Co. Maintains Buy on Vir Biotechnology, Raises Price Target to $200 CEO of Covid antibody maker Vir Biotech says its treatment ‘stands up well’ to all variants KEY POINTS: - Vir Biotechnology CEO George Scangos said the monoclonal antibody Covid treatment it developed with GlaxoSmithKline “stands up well” to all variants. - The companies announced...
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory...
Not financial advice! With the new corona variant spreading fear all over the world, PFE and MRNA are running. I think it's possible for MRNA to reclaim the bullish channel, aka the Bull-Trap that broke down, when PFE announced the Paxlovid-med. I got in MRNA way to late, now taking a risky trade, since MRNA gaps like crazy, and there's always the chance that...
$MRNA $308 or $300 bounce (If we get below then reclaim these levels, take a position for calls) Price targets: 308->310 300->305 Technical analysis: Bounce off pivot point around 308 area or bounce off psychological level at 300 Rationale: With increasing news of a new virus variant, vaccine stocks are rallying so there is built up potential for more momentum
NRx Pharmaceuticals announced that its BriLife COVID-19 Vaccine is Effectiveness Against Delta Variant. Information was released by Israel Institute for Biological Research. Since the pandemic isn`t over, there is a place in the market for new developers that have effective vaccines. I consider this a premium call, the upside i see here is 400%, or the 24usd...
With further re-opening of domestic air travel in New Zealand and potential foreign destinations opening with higher vaccination rates - it would seem a good time to start reviewing companies like Air New Zealand.
Today we will review Merck & Co stocks as I have promised recently. The company announced the launch of the first oral medication against COVID-19 with proven efficiency. Let’s analyse the chart with the Merck stocks and their upside potential. When doing analysis it is traditionally better to start from the eldest timeframes to distinguish the existing trend....
Based on the MACD Histogram projection model, a quick note that a new wave should be approaching and happening in India in December 2021, going into 2022.
Live Nation Entertainment Live Nation Entertainment, Inc. is an entertainment company, which engages in producing, marketing and selling live concerts for artists via global concert pipe. It operates through the following segments: Concerts, Sponsorship & Advertising and Ticketing. The Concerts segment involves in the promotion of live music events in owned or...
This is my end cycle market thesis. I know you can't predict market tops or timing. I'm just trying to include potential reactions to FED tapering and FED rake hikes in conjunction with an end to a long bull market run, Covid crysis and CBDC announcments.
Based on the Weekly chart... There was NO end to the wave, a slight reprieve, but it was there, clear and present. Sine the week of 19 July, it was a crossover, one that is significant and not to ignore. On the week of 30 August, the uptick was telling that the trend is real and resuming. Now SG would really feel it now as the rate is clearly accelerating over...
First off, this is not meant as any opinion towards Covid-19 (political, medical, or otherwise) nor meant in any way to dishonor any who have lost loved ones due to Covid-19, but rather I wanted to call out an interesting correlation that looks to be occurring. Recently TradingView made the confirmed cases in the US available broken down per state or country....
The current market is looking very much like the 2019 Market just before the covid sell off began in both the chart and the RSI. If we can not hold the 21 weekly MA as support, I believe a visit back to 30k is looking very likely before the next major run up to and above 100k. Without the Heavy Covid FUD of 2019, this potential sell off may not be so severe....
Nothing is more profitable than fear. I think Pfizer profits have doubled by Q2 and it's getting even crazier, way crazier. The whole west is throwing money at them with government and most urbanites in total fear. They don't even care how much it costs. Destroy a country? Lose 10% of GDP? They don't care, just name your price. Take AMZN for example. Went...
On 6/11/2021 Piper Sandler brokerage Initiated Coverage giving a price target of $18.00 VXRT Vaxart today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier. (prnewswire.com) This is in...
Biotech sector is getting hot, especially for companies connected to COVID-19 vaccine and treatments development... BIOV chart looks rip for a breakout with MACD closing in on bullish cross and a major catalyst in the form of FDA approval of its Phase I/II study: FDA Provides Necessary Guidance For BioVaxys To Begin Preparation Of Ind For Phase I/II Clinical...
Good news and even better volume today. We should see this build a base around $10 - $12. Earnings on the 29th should be interesting. VWAP rejected and momentum slowed down. Long $IPA. There is no way big pharma doesn't like this play.